WBC and Neutrophil Results in Minutes from a Fingerstick Sample

Athelas Home is an FDA-cleared, CLIA-waived hematology analyzer that delivers quantitative white blood cell count and neutrophil percentage at the point of care and at home, so care teams can act without waiting on central labs.

Same-visit results to support faster clinical decisions
Reduce missed monitoring and treatment delays tied to lab logistics
One platform that follows the patient across care settings

Get a demo

See how it works

The AI-powered device your patients will love.

40,000+

Patients supported

1,000,000+

Tests performed

When results are delayed, care is delayed.

Routine WBC and neutrophil monitoring often depends on venous draws, scheduling, transport, and lab turnaround. That friction creates missed tests, delayed decisions, and avoidable interruptions in care.

Move monitoring into the visit or the home workflow

Act on results while the patient is still in front of you

Expand access without expanding complexity

Robert Laitman, M.D.

Team Daniel Running for Recovery from Mental Illness

"Athelas Home relieves significant patient burden and lets us make treatment decisions in real time, right in the office. No extra lab orders - just results."

Hassan Minhas, M.D.

Psychiatrist and Autism Specialist in Connecticut

"Athelas Home allows us to get ANC results quickly and make treatment decisions in one visit. The technology has reduced lab coordination, shortened time to therapy, and made high-risk monitoring easier for staff and more comfortable for patients."

Nicholas Eisemann-Astone, PMHNP-BC, MSN, BS, RN, CCM

Cactus Garden Mental Health Services

"This technology has enabled clozapine for patients who had no other options."

Raymond C. Love, PharmD, BCPP, FASHP, FAACP

PharmD

"The use of finger prick blood testing instead of venipuncture is more acceptable for many patients and avoids the obstacle of traveling to a laboratory. This approach removes obstacles and offers advantages to patients who can benefit from this important medication."

Sabooh S. Mubbashar, M.D.

Medical Director, New England Psychiatric Associates

"With Athelas we've seen reduced emergency visits, reduced delays in treatment, and simplified workflows."

Actionable hematology results where care happens

Testing Parameters

What You Get

WBC

Quantitative white blood cell count

Faster decisions with fewer dependencies on high-complexity lab workflows

Neutrophil Percent

Quantitative neutrophil percentage

Less burden for patients who require frequent monitoring

ANC

Calculated to support neutrophil monitoring workflows

Consistent, repeatable workflow across settings and care teams

Built for high-frequency monitoring

Oncology and Infusion Care

Support monitoring with near-patient testing and faster decisions during visits.

Immunosuppressive Therapy

Enable routine monitoring without adding repeated lab trips that drive missed tests.

Community and Mobile Care

Bring testing to outreach settings and programs that need results on site.

Behavioral Health and Clozapine Monitoring

Reduce friction in required monitoring workflows and support continuity of treatment.

At-Home Monitoring

Enable testing from home to reduce missed labs and keep patients on therapy between visits.

Simple workflow, fast results

STEP 1

Collect a fingerstick capillary sample

STEP 2

Run the test on Athelas Home

STEP 3

Review results in minutes and take next steps

Designed for routine monitoring at scale

Supports standardized operations across clinics and distributed care models

Built to fit into existing patient visit flows

See the full workflow live and assess fit in one call

If your teams manage frequent WBC or ANC monitoring, the fastest way to evaluate impact is to see the workflow end to end.

Time to result and on-site workflow walkthrough

Operational requirements, training, and rollout plan

Patient populations and settings fit assessment

Data flow, reporting, and program operations overview

Frequently  asked questions

What results does Athelas Home provide?

Quantitative WBC and neutrophil percentage results, with ANC calculated to support monitoring workflows.

Where can it be used?

Point-of-care settings and home workflows, aligned to your program requirements and patient eligibility.

Who uses it?

Care teams managing patients who require routine WBC and neutrophil monitoring, including oncology, immunosuppression, and clozapine programs.

What does implementation look like?

A rollout plan that covers training, supplies, operations, and program setup for your sites and care model.